Goodman Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1
| Closed | -$962 | – | 206 |
|
|
2024
Q1 | $962 | Buy |
+1
| New | +$962 | ﹤0.01% | 163 |
|
|
2023
Q2 | – | Sell |
-298
| Closed | -$245K | – | 179 |
|
|
2023
Q1 | $245K | Sell |
298
-412
| -58% | -$339K | 0.13% | 44 |
|
|
2022
Q4 | $512K | Hold |
710
| – | – | 0.3% | 35 |
|
|
2022
Q3 | $489K | Sell |
710
-179
| -20% | -$123K | 0.27% | 36 |
|
|
2022
Q2 | $526K | Sell |
889
-6,287
| -88% | -$3.72M | 0.23% | 33 |
|
|
2022
Q1 | $5.01M | Sell |
7,176
-1,002
| -12% | -$700K | 1.73% | 20 |
|
|
2021
Q4 | $5.17M | Buy |
+8,178
| New | +$5.17M | 1.74% | 21 |
|